Curtis & Wyss Group is pleased to invite you to "World Adoptive T-Cell Therapy Summit" scheduled on May 29 - 30, 2017 in Lisbon, Portugal
By joining this summit of Curtis & Wyss Group, you will discuss and learn about the current issues on Adoptive T-Cell Therapy. This is an opportunity for thought leaders from biotech, big pharma, academia and the wider service community to discuss progress and share insight on strategies. This is a pivotal moment particularly because clinical progress has been made with Chimeric Antigen Receptors (CAR), T Cell Receptors (TCR), and Tumor Infiltrating Lymphocytes (TIL), making these therapies the frontrunner for curing immune-based diseases.
Therefore, we are pleased to invite you to the "World Adoptive T-Cell Therapy Summit" scheduled on May 29 - 30, 2017 in Lisbon, Portugal. This premier B2B event will enable the participants to learn about the latest developments of Adoptive T-Cell Therapy. It is an honor and privilege to invite you to participate in this Summit.
We look forward to welcoming you at the Summit in Lisbon upcoming May!
Key Practical Learning Points of the Summit:
Who should attend? Chief Executives, Executive Directors, Vice Presidents, Heads, Team Leaders and Managers of: